CINECA IRIS Institutional Research Information System

DURELLI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.405
EU - Europa 622
AS - Asia 254
OC - Oceania 23
SA - Sud America 23
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 5
Totale 2.351
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.360
IT - Italia 178
DE - Germania 126
GB - Regno Unito 62
FR - Francia 59
VN - Vietnam 59
CN - Cina 55
IN - India 39
CA - Canada 34
IE - Irlanda 23
AU - Australia 21
JP - Giappone 21
PL - Polonia 21
RU - Federazione Russa 20
ES - Italia 18
CZ - Repubblica Ceca 17
KR - Corea 17
CH - Svizzera 13
ZA - Sudafrica 13
IR - Iran 12
MY - Malesia 12
NL - Olanda 12
PT - Portogallo 11
TR - Turchia 11
RO - Romania 10
UA - Ucraina 10
BE - Belgio 8
DK - Danimarca 8
BR - Brasile 7
MX - Messico 7
SE - Svezia 7
CL - Cile 5
TW - Taiwan 5
CO - Colombia 4
FI - Finlandia 4
GR - Grecia 4
AR - Argentina 3
EG - Egitto 3
EU - Europa 3
HK - Hong Kong 3
LB - Libano 3
OM - Oman 3
SA - Arabia Saudita 3
AT - Austria 2
CU - Cuba 2
EC - Ecuador 2
HU - Ungheria 2
ID - Indonesia 2
MQ - Martinica 2
NZ - Nuova Zelanda 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AP - ???statistics.table.value.countryCode.AP??? 1
BG - Bulgaria 1
BJ - Benin 1
BY - Bielorussia 1
CY - Cipro 1
GH - Ghana 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
LT - Lituania 1
LU - Lussemburgo 1
MK - Macedonia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
SG - Singapore 1
TH - Thailandia 1
VE - Venezuela 1
Totale 2.351
Salva come PNG Salva come JPEG
Città #
Fairfield 166
Houston 121
Ashburn 93
Santa Cruz 88
Ann Arbor 87
Buffalo 84
Woodbridge 79
Seattle 69
Torino 54
Dong Ket 53
Wilmington 43
Cambridge 36
San Diego 22
Warsaw 21
Pisa 20
Dublin 18
Ottawa 17
Southampton 15
Beijing 14
Chicago 14
Clearwater 13
University Park 13
New York 12
Rome 12
Mountain View 11
Muizenberg 11
Las Vegas 10
London 10
Duncan 9
Los Angeles 9
Nürnberg 9
Wuhan 9
Boardman 8
Dallas 7
Durham 7
Kuala Lumpur 7
Leawood 7
Phoenix 7
Shanghai 7
Henderson 6
Bengaluru 5
Des Moines 5
Milan 5
Riva 5
San Francisco 5
Toronto 5
Alcalá De Henares 4
Berlin 4
Carnaxide 4
Chengdu 4
Düsseldorf 4
Lake Forest 4
Melbourne 4
Paris 4
San Jose 4
Taipei 4
Austin 3
Catania 3
Changchun 3
Chennai 3
Council Bluffs 3
Cuauhtémoc 3
Federal 3
Fleming Island 3
Frankfurt Am Main 3
Giza 3
Heidelberg 3
Istanbul 3
Madison 3
Milpitas 3
Minatomirai 3
Moscow 3
Munich 3
Muscat 3
Niagara Falls 3
Petaling Jaya 3
Porto 3
Provo 3
Redmond 3
Saint Louis 3
Seoul 3
Siete Aguas 3
Speyer 3
Turin 3
Vevey 3
Amsterdam 2
Atlanta 2
Bartlesville 2
Basel 2
Bern 2
Billericay 2
Binasco 2
Birmingham 2
Bloomsburg 2
Bondues 2
Boston 2
Chandler 2
Cleveland 2
Copenhagen 2
Crugers 2
Totale 1.485
Salva come PNG Salva come JPEG
Nome #
Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis, file e27ce42f-0acf-2581-e053-d805fe0acbaa 427
Natalizumab in Multiple Sclerosis: Long-Term Management, file e27ce42b-2a28-2581-e053-d805fe0acbaa 282
Randomized trial of thymectomy in myasthenia gravis, file e27ce42a-7c97-2581-e053-d805fe0acbaa 207
Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course, file e27ce429-b58b-2581-e053-d805fe0acbaa 169
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months, file e27ce429-ac92-2581-e053-d805fe0acbaa 159
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study., file e27ce42a-73d6-2581-e053-d805fe0acbaa 152
Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study., file e27ce42a-5c4b-2581-e053-d805fe0acbaa 133
Natalizumab-related progressive multifocal leukoencephalopathy in multiple sclerosis: Findings from an Italian independent registry, file e27ce42b-1979-2581-e053-d805fe0acbaa 131
Pregnancy epigenetic signature in T helper 17 and T regulatory cells in multiple sclerosis, file e27ce42d-bd6d-2581-e053-d805fe0acbaa 124
Gut microbiota alteration in Clinically Isolated Syndrome: a pilot study, file e27ce430-98ae-2581-e053-d805fe0acbaa 84
How to treat patients after natalizumab discontinuation: the TY-STOP 2 study, an Italian, prospective and multicenter study, file e27ce430-e6fe-2581-e053-d805fe0acbaa 84
Lack of CD4 + T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses, file e27ce42c-53d1-2581-e053-d805fe0acbaa 82
Computer assisted interactive learning in medical education: flipped classrooms of clinical neurology for medicine students, file e27ce42b-fa15-2581-e053-d805fe0acbaa 78
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS, file e27ce434-11da-2581-e053-d805fe0acbaa 72
Six year prospective immunological study of alemtuzumab treated patients: identification of markers of the clinical response, file e27ce430-98b2-2581-e053-d805fe0acbaa 70
The still under-investigated role of cognitive deficits in PML diagnosis, file e27ce430-9ee2-2581-e053-d805fe0acbaa 56
Natalizumab-related progressive multifocal leukoencephalopathy in multiple sclerosis: Findings from an Italian independent registry, file e27ce42c-0d4d-2581-e053-d805fe0acbaa 49
T HELPER 22 CELLS INCREASE IN MULTIPLE SCELROSIS PATIENTS: PHENOTYPICAL AND FUNCTIONAL CHARACTERIZATION, file e27ce426-c63a-2581-e053-d805fe0acbaa 24
Estrogen receptor-alpha regulates epigenetic changes on genomic regulatory regions: potential biomarkers in multiple sclerosis outcomes, file e27ce430-82af-2581-e053-d805fe0acbaa 15
Epigenetic therapy for Friedreich ataxia., file e27ce427-57a4-2581-e053-d805fe0acbaa 14
Chromatin remodeling in Th17 and Treg plasticity induced by E2 immunomodulation, file e27ce430-d26e-2581-e053-d805fe0acbaa 11
Improving the care of Rebif® treated Multiple Sclerosis patients: the "MSdialog" experience, file e27ce430-b2fb-2581-e053-d805fe0acbaa 8
Alemtuzumab long-lasting immunological effects: a 48 months follow-up observation, file e27ce430-877e-2581-e053-d805fe0acbaa 7
Cytomegalovirus reactivation during alemtuzumab treatment in a patient with multiple sclerosis, file e27ce430-82ad-2581-e053-d805fe0acbaa 6
MRI activity and neutralising antibody as predictors of response to interferon beta treatment in multiple sclerosis, file e27ce426-b644-2581-e053-d805fe0acbaa 4
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS, file e27ce432-4675-2581-e053-d805fe0acbaa 3
Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis, file e27ce426-b0cf-2581-e053-d805fe0acbaa 2
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with Nab, file e27ce426-b889-2581-e053-d805fe0acbaa 2
Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab, file e27ce42b-4fc4-2581-e053-d805fe0acbaa 2
Th22 cells are expanded in multiple sclerosis and are resistant to IFN- , file e27ce427-0574-2581-e053-d805fe0acbaa 1
Totale 2.458
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.567
article - articoli 0
book - libri 0
conference - conferenze 691
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.258
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019143 0 0 0 0 0 0 0 0 0 27 70 46
2019/2020413 35 26 24 46 25 21 32 49 63 26 31 35
2020/2021506 28 47 29 54 40 42 44 31 41 42 48 60
2021/2022617 56 40 37 95 87 22 29 42 24 28 112 45
2022/2023390 9 32 111 62 29 59 21 11 12 18 18 8
2023/202498 8 9 14 5 13 7 18 16 4 4 0 0
Totale 2.458